Tofacitinib (CP-690,550) in combination with methotrexate in patients with active rheumatoid arthritis with an inadequate response to tumour necrosis factor inhibitors: a randomised phase 3 trial - Burmester, G R; Blanco, R; Charles-Schoeman, C (Lancet, 2013)
et al.